Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field.

Teva Pharmaceutical Industries (NYSE:TEVA) saw its stock price move up 14% over the last week, a notable jump attributed ...

Teva Pharmaceutical ADR shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

HighTower Advisors LLC raised its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 32.3% in ...

Stanley Druckenmiller, whose net worth is around $6.9 billion, made most of his fortune as a hedge fund manager, and became a ...

The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry ...

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel ...

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teva ...

Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned an average rating of ...

Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a ...